In patients with medlinkchronic kidney disease/medlink, irreversible disease progression is triggered by the loss of podocytes, essential components...
Vous n'êtes pas connecté
The CRISPR tool is capable of repairing the genetic defect responsible for the immune disease chronic granulomatous disease.
In patients with medlinkchronic kidney disease/medlink, irreversible disease progression is triggered by the loss of podocytes, essential components...
A team of researchers has identified how the APOE4 protein, a major genetic risk factor for Alzheimer's disease, can negatively impact brain health....
The first patient to receive gene therapy for sickle cell disease since its approval is finally home. The New York Times reported that staff members...
CRISPR Therapeutics reports mixed third-quarter results. The commercial launch of the first CRISPR-based gene therapy, Casgevy, is progressing well.
In healthy brains, immune cells called microglia patrol for damage, clearing away debris and harmful proteins. But in the presence of the APOE4...
Cancer, a disease with a global impact, is intricately linked to dysregulated gene expression, which is influenced by both genetic mutations and...
Advocates urge government to allow ‘precision breeding’ to combat disease, but RSPCA warns of ethical dangers
Bajra, or pearl millet, is a highly nutritious grain that offers numerous health benefits, making it a significant addition to any diet. Here are some...
Sierra Leone Telegraph: 31 October 2024: Partnership for Healthy Cities, a global network of 74 cities committed to saving lives by preventing...
HuidaGene Therapeutics (HuidaGene), a global clinical─stage biotechnology company developing genome medicines, announced that the US FDA has cleared...